Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Acq. announced
Director departure
Letter to company
Asset disposition
Appointed director
|
|
NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/03/2023 |
SC 13D/A
| Scott John K Jr. reports a 75% stake in Navidea Biopharmaceuticals, Inc. |
| 06/16/2023 |
SC 13D/A
| Scott John K Jr. reports a 52.8% stake in Navidea Biopharmaceuticals, Inc. |
| 09/22/2022 |
SC 13D/A
| Scott John K Jr. reports a 45.7% stake in Navidea Biopharmaceuticals, Inc. |
| 09/14/2022 |
SC 13D/A
| Scott John K Jr. reports a 45.7% stake in Navidea Biopharmaceuticals, Inc. |
| 04/22/2022 |
SC 13D/A
| Scott John K Jr. reports a 31.6% stake in Navidea Biopharmaceuticals, Inc. |
| 07/23/2021 |
SC 13D/A
| Scott John K Jr. reports a 32.8% stake in Navidea Biopharmaceuticals, Inc. |
| 06/15/2021 |
SC 13D/A
| Scott John K Jr. reports a 32.8% stake in Navidea Biopharmaceuticals, Inc. |
| 04/05/2021 |
SC 13D/A
| Scott John K Jr. reports a 33.3% stake in Navidea Biopharmaceuticals, Inc. |
| 03/11/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 03/05/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 12/29/2020 |
SC 13D/A
| Scott John K Jr. reports a 30.2% stake in Navidea Biopharmaceuticals, Inc. |
| 09/02/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/26/2020 |
SC 13D/A
| Scott John K Jr. reports a 33.2% stake in Navidea Biopharmaceuticals, Inc. |
| 12/12/2019 |
SC 13D/A
| Scott John K Jr. reports a 28.2% stake in Navidea Biopharmaceuticals, Inc. |
| 06/28/2016 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend] |
| 04/12/2016 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
| 03/18/2016 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
| 06/04/2012 |
SC 13D/A
| Platinum-Montaur Life Sciences, LLC reports a 10% stake in Navidea Biopharmaceuticals, Inc. |
| 04/21/2011 |
SC 13D/A
| NEOPROBE CORP reports a 10% stake in Neoprobe Corporation |
| 11/05/1998 |
SC 13D/A
| KNOWLTON BROTHERS INC reports a 4.4% stake in NEOPROBE CORPORATION |
| 10/19/1998 |
SC 13D/A
| KNOWLTON BROTHERS INC reports a 4.4% stake in NEOPROBE CORPORATION |
|
|